Korro Bio Stock Forecast
NASDAQ: KRROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
KRRO analyst consensus
Consensus (11 analysts)
strong_buy
Avg. price target
$20.20+90.93%
- Strong buy 2
- Buy 8
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 11 Wall Street analysts covering Korro Bio (2026-10-08), 10 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $20.20, with a high estimate of $30.00 and a low estimate of $10.00. The average target implies upside of 90.9% from the current price of $10.58.
The spread between the highest and lowest targets is 200.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for KRRO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 18% |
| Buy | 8 | 73% |
| Hold | 1 | 9% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $10.00 | -5.48% |
| Average target | $20.20 | +90.93% |
| High target | $30.00 | +183.55% |